Recent results could lead to the new therapy's approval as a better alternative to matched-donor stem-cell transplantsMarch 18, 2025Check out STAT+Sponsored By Sebastian Scheiner/AP STAT+ | Purified T cell transplant lowers risk of immune reaction for blood cancer patients, study shows Privately hold Orca Bio intends to seek approval from the Food and Drug Administration for the off-the-shelf therapy. By Adam Feuerstein STAT+ | After a big donor sought care from a Dana-Farber cancer doctor, things went awry A doctor's failure to keep medical records violated state regulations and ethical standards for physicians, a legal complaint contends. By Liz Kowalczyk — Boston Globe STAT+ | Belgian anti-trust authorities probe Roche for allegedly delaying biosimilars of two cancer meds The probe is the latest effort by the European Commission and European countries to scrutinize potential antitrust behavior by drugmakers By Ed Silverman More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Cancer Briefing? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments